Kathmann Markus, Flau Karsten, Redmer Agnes, Tränkle Christian, Schlicker Eberhard
Department of Pharmacology and Toxicology, School of Medicine, University of Bonn, Reuterstr. 2b, 53113 Bonn, Germany.
Naunyn Schmiedebergs Arch Pharmacol. 2006 Feb;372(5):354-61. doi: 10.1007/s00210-006-0033-x. Epub 2006 Feb 18.
The mechanism of action of cannabidiol, one of the major constituents of cannabis, is not well understood but a noncompetitive interaction with mu opioid receptors has been suggested on the basis of saturation binding experiments. The aim of the present study was to examine whether cannabidiol is an allosteric modulator at this receptor, using kinetic binding studies, which are particularly sensitive for the measurement of allosteric interactions at G protein-coupled receptors. In addition, we studied whether such a mechanism also extends to the delta opioid receptor. For comparison, (-)-Delta9-tetrahydrocannabinol (THC; another major constituent of cannabis) and rimonabant (a cannabinoid CB1 receptor antagonist) were studied. In mu opioid receptor binding studies on rat cerebral cortex membrane homogenates, the agonist 3H-DAMGO bound to a homogeneous class of binding sites with a KD of 0.68+/-0.02 nM and a Bmax of 203+/-7 fmol/mg protein. The dissociation of 3H-DAMGO induced by naloxone 10 microM (half life time of 7+/-1 min) was accelerated by cannabidiol and THC (at 100 microM, each) by a factor of 12 and 2, respectively. The respective pEC50 values for a half-maximum elevation of the dissociation rate constant k(off) were 4.38 and 4.67; 3H-DAMGO dissociation was not affected by rimonabant 10 microM. In delta opioid receptor binding studies on rat cerebral cortex membrane homogenates, the antagonist 3H-naltrindole bound to a homogeneous class of binding sites with a KD of 0.24+/-0.02 nM and a Bmax of 352+/-22 fmol/mg protein. The dissociation of 3H-naltrindole induced by naltrindole 10 microM (half life time of 119+/-3 min) was accelerated by cannabidiol and THC (at 100 microM, each) by a factor of 2, each. The respective pEC50 values were 4.10 and 5.00; 3H-naltrindole dissociation was not affected by rimonabant 10 microM. The present study shows that cannabidiol is an allosteric modulator at mu and delta opioid receptors. This property is shared by THC but not by rimonabant.
大麻的主要成分之一——大麻二酚的作用机制尚未完全明确,但基于饱和结合实验,有人提出它与μ阿片受体存在非竞争性相互作用。本研究的目的是利用动力学结合研究来检验大麻二酚是否是该受体的变构调节剂,这种研究方法对测量G蛋白偶联受体的变构相互作用特别敏感。此外,我们还研究了这种机制是否也适用于δ阿片受体。作为比较,我们对(-)-Δ⁹-四氢大麻酚(THC;大麻的另一种主要成分)和利莫那班(一种大麻素CB1受体拮抗剂)进行了研究。在对大鼠大脑皮质膜匀浆进行的μ阿片受体结合研究中,激动剂³H-DAMGO与一类同质的结合位点结合,其解离常数KD为0.68±0.02 nM,最大结合量Bmax为203±7 fmol/mg蛋白。10 μM纳洛酮诱导的³H-DAMGO解离(半衰期为7±1分钟)分别被大麻二酚和THC(均为100 μM)加速了12倍和2倍。解离速率常数k(off)升高至最大值一半时的各自pEC50值分别为4.38和4.67;10 μM利莫那班对³H-DAMGO解离没有影响。在对大鼠大脑皮质膜匀浆进行的δ阿片受体结合研究中,拮抗剂³H-纳曲吲哚与一类同质的结合位点结合,其解离常数KD为0.24±0.02 nM,最大结合量Bmax为352±22 fmol/mg蛋白。10 μM纳曲吲哚诱导的³H-纳曲吲哚解离(半衰期为119±3分钟)分别被大麻二酚和THC(均为100 μM)加速了2倍。各自的pEC50值分别为4.10和5.00;10 μM利莫那班对³H-纳曲吲哚解离没有影响。本研究表明,大麻二酚是μ和δ阿片受体的变构调节剂。THC也具有这一特性,但利莫那班没有。